Project Grant HT94252510910
Award Date 9/1/25
Completion Date 8/31/28
Dollars Obligated $268K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
San Antonio, TX 78216, USA
Similar Awards
- The federal Project Grant award in the amount of $1,845,076.00 was provided by the Defense Health Agency (DHA) under the Military Medical Research and Development (CFDA 12.420) program. The funding supports the Metis Foundation, a non-profit organization in San Antonio, Texas, to develop novel therapeutics that target innate immune responses for treating multiple organ failure in severe polytrauma during prolonged casualty care. The grant, with a performance period from November 1, 2024 to...
- The Defense Health Agency awarded a $398,107 Cooperative Agreement to the Metis Foundation, a non-profit organization, under the Military Medical Research and Development program (CFDA 12.420). The funding supports a 3-year project to develop a multi-modal approach to reduce vascularized composite allotransplantation (VCA) immunogenicity and improve functional outcomes. The Metis Foundation has an extensive history providing medical research, products, and services through prime and sub...
- This $1,097,466 Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports the development of portable integrated optic biosensors. These biosensors are intended to help identify early indications of potential loss of native tissue in the reconstruction of complex upper extremity amputations. The 2-year grant awarded to the Metis Foundation, a non-profit research organization, will fund the research, development, and...
- This $864,533 Project Grant was awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to the Metis Foundation, a non-profit organization based in San Antonio, Texas. The purpose of this 3-year award, with a performance period from September 30, 2025 to September 29, 2028, is to conduct research on the association between PFAS and other toxic military exposures and pancreatic cancer risk in a military population. The Metis Foundation, which...
- The Defense Health Agency awarded a $264,000 cooperative agreement to the Metis Foundation from September 30, 2022 to September 29, 2025 under the Military Medical Research and Development program (CFDA 12.420). The award will support the Metis Foundation's ACTIVE REJECTION MICRO-PATCH SURVEILLANCE (ARMS) SYSTEM FOR VASCULARIZED COMPOSITE ALLOGRAFTS project located in San Antonio, TX. Through this funding, the Metis Foundation will develop an ARMS system to monitor vascularized composite...
- The Defense Health Agency awarded a $488,086 Project Grant to The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. under the Military Medical Research and Development program (CFDA 12.420). The grant, titled "BIOMARKER SIGNATURES OF POST-TRAUMATIC EPILEPTOGENESIS (PTEGENESIS) AND ITS TREATMENTS," is intended to support advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the public. The performance period...
- The Defense Health Agency awarded a $1.687 million Project Grant to the Icahn School of Medicine at Mount Sinai under the Military Medical Research and Development federal grant program (CFDA 12.420) for the period of May 1, 2023 to April 30, 2027. The grant will fund research investigating the role of medial amygdala circuits in mediating the effects of diet on post-traumatic behavioral and metabolic complications. Through basic, applied, and advanced biomedical research, this project aims to...
- The Defense Health Agency awarded a $682,049 Project Grant to The Washington University under the Military Medical Research and Development program (CFDA 12.420). The grant will fund a research project from August 1, 2023 to July 31, 2026 to leverage a precision medicine platform to predict novel therapies for malignant peripheral nerve sheath tumors. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform military and public...
- This Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) provides $400,400 to Wayne State University in Detroit, MI to conduct research on "Harnessing Immunometabolism to Ameliorate the Pathology of Ocular Chemical Injuries". The project aims to transform healthcare for military service members and the broader public by advancing innovative biomedical research on addressing medical challenges relevant to the military. The...
- The Defense Health Agency awarded a $498,896 Project Grant through the Military Medical Research and Development program (CFDA 12.420) to The Schepens Eye Research Institute, Inc. in Boston, MA. The grant supports a 2-year research project investigating the use of noninvasive transpalpebral electrical stimulation as a therapy for combat-related corneal trauma. As an experienced performer of prior federal grants from agencies like the NIH, DoD, and Army, the non-profit Schepens Eye Research...
The Department of Defense (DOD) Defense Health Agency awarded a $267,544 Project Grant to the Metis Foundation in San Antonio, Texas under the Military Medical Research and Development program (CFDA 12.420). The grant provides funding from September 1, 2025 through August 31, 2028 to support research on the therapeutic effects of a peroxisome proliferator-activated receptor alpha agonist on combat-induced proliferative vitreoretinopathy. Metis Foundation, a non-profit organization focused on military medical research and innovative healthcare solutions, will coordinate this advanced biomedical research project, which aims to develop novel treatments for vision-related injuries sustained by service members.
Generated 10/21/25, 6:06 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $267.5k | 8/12/25 |